(VIANEWS) – Pacira BioSciences (PCRX), Zoom (ZM), Option Care Health (OPCH) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Pacira BioSciences (PCRX)

37.1% sales growth and 5.65% return on equity

Pacira BioSciences, Inc. offers non-opioid pain relief and regenerative healthcare solutions to health professionals and patients throughout the United States.

Pacira BioSciences’s sales growth this year is expected to be 29.2% and 15.2% for next year.

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 580.5M for the twelve trailing months.

Volume

Today’s last reported volume for Pacira BioSciences is 302829 which is 38.41% below its average volume of 491745.

Pacira BioSciences’s sales growth is a negative 0% for the current quarter and 37.1% for the next. The company’s growth estimates for the current quarter and the next is 14.3% and 34.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.65%.

Volatility

Pacira BioSciences’s last day, last week, and last month’s current intraday variation average was 0.37%, 0.95%, and 1.56%, respectively.

Pacira BioSciences’s highest amplitude of average volatility was 2.24% (day), 2.65% (last week), and 3.80% (last month), respectively.

Pacira BioSciences’s Stock Yearly Top and Bottom Value

Pacira BioSciences’s stock is valued at $56.56 at 16:22 EST, way below its 52-week high of $82.16 and way above its 52-week low of $45.05.

Pacira BioSciences’s Moving Average

Pacira BioSciences’s value is below its 50-day moving average of $57.76 and below its 200-day moving average of $62.19.

2. Zoom (ZM)

15.3% sales growth and 34.64% return on equity

Zoom Video Communications, Inc. offers a video-first communication platform for the Americas, Asia Pacific, Europe, Middle East, Middle East, Africa.

Zoom’s sales growth this year is anticipated to be 51.5% and 18% for next year.

Year-on-year quarterly revenue growth grew by 35.2%, now sitting on 3.91B for the twelve trailing months.

Volume

Today’s last reported volume for Zoom is 2111960 which is 60.58% below its average volume of 5357970.

Zoom’s sales growth is a negative 0% for the ongoing quarter and 15.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 10.1% and negative -13.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.64%.

Volatility

Zoom’s last day, last week, and last month’s current intraday variation average was 0.88%, 1.28%, and 2.46%, respectively.

Zoom’s highest amplitude of average volatility was 5.00% (day), 4.43% (last week), and 5.10% (last month), respectively.

Zoom’s Stock Yearly Top and Bottom Value

Zoom’s stock is valued at $113.22 at 16:22 EST, way under its 52-week low of $175.27.

Zoom’s Moving Average

Zoom’s value is way below its 50-day moving average of $246.95 and way under its 200-day moving average of $312.18.

Previous days news about Zoom(ZM)

  • According to GlobeNewsWire on Monday, 1 August, "Given our two decades of cyber security innovation and experience, we now provide our own secure video conferencing platform solution, as well as security solutions that overlay onto other commonly used video conferencing platforms, such as Zoom and MS Teams," said Mark Kay, Zerify’s Chairman and CEO."
  • According to VentureBeat on Tuesday, 2 August, "By the time I sit down at my desk to start the workday, I’ve already gone through a dozen points of access control – including disarming and re-arming my house alarm with a code, unlocking my iPhone with Face ID, opening and starting my car with a key fob, logging onto my laptop with a biometric like fingerprint touch, and joining my first meeting of the day with a secure Microsoft Teams or Zoom link."

3. Option Care Health (OPCH)

10.5% sales growth and 14.96% return on equity

Option Care Health, Inc. provides infusion services at home or on an alternate location in the United States.

Option Care Health’s sales growth this year is anticipated to be 13.8% and 8.1% for next year.

Year-on-year quarterly revenue growth grew by 14%, now sitting on 3.72B for the twelve trailing months.

Volume

Today’s last reported volume for Option Care Health is 762674 which is 31.65% below its average volume of 1115860.

Option Care Health’s sales growth for the next quarter is 10.5%. The company’s growth estimates for the ongoing quarter and the next is 5% and negative -43.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.96%.

Volatility

Option Care Health’s last day, last week, and last month’s current intraday variation average was 0.79%, 1.44%, and 1.56%, respectively.

Option Care Health’s highest amplitude of average volatility was 2.92% (day), 3.24% (last week), and 3.55% (last month), respectively.

Option Care Health’s Stock Yearly Top and Bottom Value

Option Care Health’s stock is valued at $34.49 at 16:22 EST, below its 52-week high of $35.57 and way above its 52-week low of $20.88.

Option Care Health’s Moving Average

Option Care Health’s value is way above its 50-day moving average of $29.83 and way higher than its 200-day moving average of $27.30.

4. Penske Automotive Group (PAG)

10.2% sales growth and 36.03% return on equity

Penske Automotive Group, Inc., is a multi-service transportation company that operates commercial and automotive truck dealerships.

Penske Automotive Group’s sales growth this year is anticipated to be 9.2% and 3.5% for next year.

Year-on-year quarterly revenue growth grew by 20.8%, now sitting on 26.76B for the twelve trailing months.

Volume

Today’s last reported volume for Penske Automotive Group is 385935 which is 1.48% above its average volume of 380272.

Penske Automotive Group’s sales growth is a negative 0% for the current quarter and 10.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 0% and negative -5.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.03%.

Volatility

Penske Automotive Group’s last day, last week, and last month’s current intraday variation average was 1.02%, 2.13%, and 2.11%, respectively.

Penske Automotive Group’s highest amplitude of average volatility was 2.83% (day), 3.66% (last week), and 3.71% (last month), respectively.

Penske Automotive Group’s Stock Yearly Top and Bottom Value

Penske Automotive Group’s stock is valued at $110.06 at 16:22 EST, way under its 52-week high of $123.60 and way above its 52-week low of $78.60.

Penske Automotive Group’s Moving Average

Penske Automotive Group’s worth is under its 50-day moving average of $110.92 and higher than its 200-day moving average of $104.64.

5. Ritchie Bros. Auctioneers Incorporated (RBA)

9.3% sales growth and 27% return on equity

Ritchie Bros. Auctioneers Incorporated is an asset management company and disposition firm that sells durable equipment through unreserved on-site auctions, online marketplaces and listing services.

Ritchie Bros. Auctioneers Incorporated’s sales growth this year is expected to be 12.3% and 6.8% for next year.

Year-on-year quarterly revenue growth grew by 18.8%, now sitting on 1.48B for the twelve trailing months.

Volume

Today’s last reported volume for Ritchie Bros. Auctioneers Incorporated is 282494 which is 45.12% below its average volume of 514755.

Ritchie Bros. Auctioneers Incorporated’s sales growth for the next quarter is 9.3%. The company’s growth estimates for the present quarter and the next is 13% and 55.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27%.

Volatility

Ritchie Bros. Auctioneers Incorporated’s last day, last week, and last month’s current intraday variation average was 1.76%, 1.67%, and 2.49%, respectively.

Ritchie Bros. Auctioneers Incorporated’s highest amplitude of average volatility was 2.47% (day), 2.53% (last week), and 3.30% (last month), respectively.

Ritchie Bros. Auctioneers Incorporated’s Stock Yearly Top and Bottom Value

Ritchie Bros. Auctioneers Incorporated’s stock is valued at $69.17 at 16:22 EST, under its 52-week high of $76.18 and way above its 52-week low of $48.65.

Ritchie Bros. Auctioneers Incorporated’s Moving Average

Ritchie Bros. Auctioneers Incorporated’s value is way above its 50-day moving average of $62.41 and way above its 200-day moving average of $61.84.

6. Synopsys (SNPS)

9.2% sales growth and 17.66% return on equity

Synopsys, Inc. offers electronic design automation software that can be used to test and design integrated circuits.

Synopsys’s sales growth this year is anticipated to be 19.1% and 11.5% for next year.

Year-on-year quarterly revenue growth grew by 30.9%, now sitting on 4.5B for the twelve trailing months.

Volume

Today’s last reported volume for Synopsys is 500768 which is 47.84% below its average volume of 960106.

Synopsys’s sales growth is a negative 0% for the ongoing quarter and 9.2% for the next. The company’s growth estimates for the present quarter and the next is 9.9% and negative -5.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.66%.

Volatility

Synopsys’s last day, last week, and last month’s current intraday variation average was 0.54%, 0.55%, and 1.46%, respectively.

Synopsys’s highest amplitude of average volatility was 2.78% (day), 2.31% (last week), and 2.70% (last month), respectively.

Synopsys’s Stock Yearly Top and Bottom Value

Synopsys’s stock is valued at $374.22 at 16:22 EST, under its 52-week high of $377.60 and way higher than its 52-week low of $255.02.

Synopsys’s Moving Average

Synopsys’s value is way higher than its 50-day moving average of $314.72 and way above its 200-day moving average of $318.92.

7. Ituran Location and Control Ltd. (ITRN)

6.6% sales growth and 27.34% return on equity

Ituran Location and Control Ltd. and its subsidiaries offer location-based services and products for wireless communication.

Ituran Location and Control Ltd.’s sales growth this year is expected to be 8.4% and 9.8% for next year.

Year-on-year quarterly revenue growth grew by 7%, now sitting on 275.59M for the twelve trailing months.

Volume

Today’s last reported volume for Ituran Location and Control Ltd. is 34890 which is 12.7% below its average volume of 39969.

Ituran Location and Control Ltd.’s sales growth for the next quarter is 6.6%. The company’s growth estimates for the present quarter and the next is 6.8% and 6.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.34%.

Volatility

Ituran Location and Control Ltd.’s last day, last week, and last month’s current intraday variation average was 1.56%, 1.43%, and 1.11%, respectively.

Ituran Location and Control Ltd.’s highest amplitude of average volatility was 1.92% (day), 1.83% (last week), and 2.28% (last month), respectively.

Ituran Location and Control Ltd.’s Stock Yearly Top and Bottom Value

Ituran Location and Control Ltd.’s stock is valued at $25.40 at 16:22 EST, way under its 52-week high of $29.85 and way above its 52-week low of $19.73.

Ituran Location and Control Ltd.’s Moving Average

Ituran Location and Control Ltd.’s worth is higher than its 50-day moving average of $24.14 and above its 200-day moving average of $24.28.

LEAVE A REPLY

Please enter your comment!
Please enter your name here